401 Watson Blvd
The Broome County Health Department and Care Compass Network are sponsoring a free buprenorphine waiver training for clinical providers. In response to the opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid overdose disorder is urgently needed. Physicians, Nurse Practitioners and Physician Assistants are eligible for the buprenorphine waiver certificate. We highly encourage Pharmacists, Nurses, Social Workers and other licensed professionals to attend to further their education and knowledge on the importance of this medication assisted treatment.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a ‘half and-half’ format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
DSRIP Project 3ai Model 1 Training: Reimbursement is available for CCN contracted partners ($500 value). Funds will be disbursed to the participants’ contracted entity. Participants need to coordinate internally with their organization. To be reimbursed:
• Participants must sign in and stay for entire training AND complete the required online sessions to receive the waiver certificate
• Contracted entity will submit a signed attestation letter and a copy of the participant’s waiver certificate to CCN for approval
CME CREDITS PENDING:
The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 4 (four) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been reviewed and is acceptable for up to 4 (four) Nursing Contact Hours.
This course has been approved for 4 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers JA4008192-0000-19-001-H01-P (pharmacy) and JA4008192-0000-19-001-H01-T (pharmacy tech).
Trainers: Julia Hunter, MD, United Health Services, Binghamton, NY; Peter Ronan, MD, United Health Services, Binghamton, NY
Dr. Julia Hunter is board-certified in both Family Medicine and Addiction Medicine. She completed a fellowship in Addiction Medicine at Summa Health in Akron, Ohio. As a fellow, she was named a Ruth Fox Scholar by the American Society of Addiction Medicine. She is a fellow in the American Society of Addiction Medicine. With Dr. Ronan, Dr. Hunter oversees the clinical teams in our inpatient, outpatient, opioid treatment, and buprenorphine/naloxone programs. She created and runs the alcohol and sedative hypnotic consultation service and the comprehensive program for pregnant women with opioid use disorder. She implemented the Hub and Spoke model for treating opioid use disorder in the UHS system. She is interested in fighting addiction’s stigma, treating hepatitis C in people who inject drugs, and managing addiction in pregnancy.
Dr. Peter Ronan is board-certified in Internal Medicine and a fellow in the American Society of Addiction Medicine. He is the Medical Director of Addiction Medicine and the Assistant Medical Director of the UHS Hospital System. Dr. Ronan has been working in the field of Addiction Medicine for over 30 years. He started the Addiction Medicine department’s buprenorphine/naloxone program in 2003 and ran the hospital’s medically supervised withdrawal unit before it was converted into additional beds in inpatient New Horizons. He supervises the clinical teams in our inpatient, outpatient, opioid treatment, and buprenorphine/naloxone programs. He is currently overseeing the expansion of our opioid treatment program.